Genetic variation in plant CYP51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.

Brassinosteroids (BRs) are plant steroid hormones with structural similarity to mammalian sex steroids and ecdysteroids from insects. The BRs are synthesized from sterols and are essential regulators of cell division, cell elongation and cell differentiation. In this work we show that voriconazole,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wilfried Rozhon, Sigrid Husar, Florian Kalaivanan, Mamoona Khan, Markus Idlhammer, Daria Shumilina, Theo Lange, Thomas Hoffmann, Wilfried Schwab, Shozo Fujioka, Brigitte Poppenberger
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/87ed7f749f8a444382ce240a12dd58d4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:87ed7f749f8a444382ce240a12dd58d4
record_format dspace
spelling oai:doaj.org-article:87ed7f749f8a444382ce240a12dd58d42021-11-18T08:01:26ZGenetic variation in plant CYP51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.1932-620310.1371/journal.pone.0053650https://doaj.org/article/87ed7f749f8a444382ce240a12dd58d42013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23335967/?tool=EBIhttps://doaj.org/toc/1932-6203Brassinosteroids (BRs) are plant steroid hormones with structural similarity to mammalian sex steroids and ecdysteroids from insects. The BRs are synthesized from sterols and are essential regulators of cell division, cell elongation and cell differentiation. In this work we show that voriconazole, an antifungal therapeutic drug used in human and veterinary medicine, severely impairs plant growth by inhibiting sterol-14α-demethylation and thereby interfering with BR production. The plant growth regulatory properties of voriconazole and related triazoles were identified in a screen for compounds with the ability to alter BR homeostasis. Voriconazole suppressed growth of the model plant Arabidopsis thaliana and of a wide range of both monocotyledonous and dicotyledonous plants. We uncover that voriconazole toxicity in plants is a result of a deficiency in BRs that stems from an inhibition of the cytochrome P450 CYP51, which catalyzes a step of BR-dependent sterol biosynthesis. Interestingly, we found that the woodland strawberry Fragaria vesca, a member of the Rosaceae, is naturally voriconazole resistant and that this resistance is conferred by the specific CYP51 variant of F. vesca. The potential of voriconazole as a novel tool for plant research is discussed.Wilfried RozhonSigrid HusarFlorian KalaivananMamoona KhanMarkus IdlhammerDaria ShumilinaTheo LangeThomas HoffmannWilfried SchwabShozo FujiokaBrigitte PoppenbergerPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 1, p e53650 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Wilfried Rozhon
Sigrid Husar
Florian Kalaivanan
Mamoona Khan
Markus Idlhammer
Daria Shumilina
Theo Lange
Thomas Hoffmann
Wilfried Schwab
Shozo Fujioka
Brigitte Poppenberger
Genetic variation in plant CYP51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.
description Brassinosteroids (BRs) are plant steroid hormones with structural similarity to mammalian sex steroids and ecdysteroids from insects. The BRs are synthesized from sterols and are essential regulators of cell division, cell elongation and cell differentiation. In this work we show that voriconazole, an antifungal therapeutic drug used in human and veterinary medicine, severely impairs plant growth by inhibiting sterol-14α-demethylation and thereby interfering with BR production. The plant growth regulatory properties of voriconazole and related triazoles were identified in a screen for compounds with the ability to alter BR homeostasis. Voriconazole suppressed growth of the model plant Arabidopsis thaliana and of a wide range of both monocotyledonous and dicotyledonous plants. We uncover that voriconazole toxicity in plants is a result of a deficiency in BRs that stems from an inhibition of the cytochrome P450 CYP51, which catalyzes a step of BR-dependent sterol biosynthesis. Interestingly, we found that the woodland strawberry Fragaria vesca, a member of the Rosaceae, is naturally voriconazole resistant and that this resistance is conferred by the specific CYP51 variant of F. vesca. The potential of voriconazole as a novel tool for plant research is discussed.
format article
author Wilfried Rozhon
Sigrid Husar
Florian Kalaivanan
Mamoona Khan
Markus Idlhammer
Daria Shumilina
Theo Lange
Thomas Hoffmann
Wilfried Schwab
Shozo Fujioka
Brigitte Poppenberger
author_facet Wilfried Rozhon
Sigrid Husar
Florian Kalaivanan
Mamoona Khan
Markus Idlhammer
Daria Shumilina
Theo Lange
Thomas Hoffmann
Wilfried Schwab
Shozo Fujioka
Brigitte Poppenberger
author_sort Wilfried Rozhon
title Genetic variation in plant CYP51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.
title_short Genetic variation in plant CYP51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.
title_full Genetic variation in plant CYP51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.
title_fullStr Genetic variation in plant CYP51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.
title_full_unstemmed Genetic variation in plant CYP51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.
title_sort genetic variation in plant cyp51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/87ed7f749f8a444382ce240a12dd58d4
work_keys_str_mv AT wilfriedrozhon geneticvariationinplantcyp51sconfersresistanceagainstvoriconazoleanovelinhibitorofbrassinosteroiddependentsterolbiosynthesis
AT sigridhusar geneticvariationinplantcyp51sconfersresistanceagainstvoriconazoleanovelinhibitorofbrassinosteroiddependentsterolbiosynthesis
AT floriankalaivanan geneticvariationinplantcyp51sconfersresistanceagainstvoriconazoleanovelinhibitorofbrassinosteroiddependentsterolbiosynthesis
AT mamoonakhan geneticvariationinplantcyp51sconfersresistanceagainstvoriconazoleanovelinhibitorofbrassinosteroiddependentsterolbiosynthesis
AT markusidlhammer geneticvariationinplantcyp51sconfersresistanceagainstvoriconazoleanovelinhibitorofbrassinosteroiddependentsterolbiosynthesis
AT dariashumilina geneticvariationinplantcyp51sconfersresistanceagainstvoriconazoleanovelinhibitorofbrassinosteroiddependentsterolbiosynthesis
AT theolange geneticvariationinplantcyp51sconfersresistanceagainstvoriconazoleanovelinhibitorofbrassinosteroiddependentsterolbiosynthesis
AT thomashoffmann geneticvariationinplantcyp51sconfersresistanceagainstvoriconazoleanovelinhibitorofbrassinosteroiddependentsterolbiosynthesis
AT wilfriedschwab geneticvariationinplantcyp51sconfersresistanceagainstvoriconazoleanovelinhibitorofbrassinosteroiddependentsterolbiosynthesis
AT shozofujioka geneticvariationinplantcyp51sconfersresistanceagainstvoriconazoleanovelinhibitorofbrassinosteroiddependentsterolbiosynthesis
AT brigittepoppenberger geneticvariationinplantcyp51sconfersresistanceagainstvoriconazoleanovelinhibitorofbrassinosteroiddependentsterolbiosynthesis
_version_ 1718422614232268800